文献速递眼底病与葡萄膜炎

中国糖尿病视网膜病变的患病率与危险因素:一项多医院横断面研究

Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study.
PubMed 文献 · Br J Ophthalmol · 2017-08-30

该研究基于中国八家医院2014年1月至2016年7月的糖尿病视网膜病变筛查项目,纳入16305例糖尿病患者,其中15078例(92.5%)眼底照片可分级。年龄-性别标化的任何糖尿病视网膜病变患病率为27.9%(95%CI 27.2%~28.6%),威胁视力的糖尿病视网膜病变为12.6%(95%CI 12.1%~13.1%);多因素logistic回归显示年龄较轻、糖尿病病程较长、糖化血红蛋白较高、空腹血糖较高、收缩压较高、心率较快、低密度脂蛋白较高、甘油三酯较低、血尿素氮较高及血肌酐升高与糖尿病视网膜病变相关。

要点

  • 中国八家医院糖尿病患者中,年龄-性别标化的任何糖尿病视网膜病变患病率为27.9%,威胁视力的糖尿病视网膜病变为12.6%。
  • 15078例(92.5%)患者的眼底照片可分级,糖尿病视网膜病变分级由汕头国际眼科中心阅片中心视网膜专科医师按英国国家筛查项目标准完成。
  • 年龄较轻、糖尿病病程较长、糖化血红蛋白较高、空腹血糖较高、收缩压较高、低密度脂蛋白较高等与糖尿病视网膜病变相关;除血尿素氮和甘油三酯外,类似因素与威胁视力的糖尿病视网膜病变相关。

核心结论

  • 中国多医院糖尿病患者中,任何糖尿病视网膜病变和威胁视力的糖尿病视网膜病变的年龄-性别标化患病率分别为27.9%(95%CI 27.2%~28.6%)和12.6%(95%CI 12.1%~13.1%)。
  • 与中国糖尿病患者相比,西方糖尿病患者的糖尿病视网膜病变和威胁视力的糖尿病视网膜病变危险因素相似。

研究设计与样本

  • 该研究为多医院横断面研究,基于中国八家医院(覆盖南方和北方)2014年1月至2016年7月的糖尿病视网膜病变筛查项目(Lifeline Express Diabetic Retinopathy Screening Program)。
  • 共筛查16305例糖尿病患者,其中15078例(92.5%)眼底照片可分级;所有参与者接受标准化访谈和检查并接受数字眼底照相。
  • 糖尿病视网膜病变严重程度由汕头国际眼科中心阅片中心视网膜专科医师根据英国国家筛查项目分级标准从眼底照片评定。
  • 威胁视力的糖尿病视网膜病变定义为存在增殖前期糖尿病视网膜病变(R2)、增殖期糖尿病视网膜病变(R3)和/或黄斑病变(M1)。

主要发现

  • 任何糖尿病视网膜病变的年龄-性别标化患病率为27.9%(95%CI 27.2%~28.6%),威胁视力的糖尿病视网膜病变为12.6%(95%CI 12.1%~13.1%)。
  • 多因素logistic回归中,年龄较轻(OR 0.967)、糖尿病病程较长(OR 1.093)、糖化血红蛋白较高(OR 1.115)、空腹血糖较高(OR 1.074)、收缩压较高(OR 1.014)、心率较快(OR 1.010)、低密度脂蛋白较高(OR 1.149)、甘油三酯较低(OR 0.975)、血尿素氮较高(OR 1.012)及血肌酐升高(OR 1.003)与糖尿病视网膜病变的存在相关。
  • 除血尿素氮和甘油三酯外,类似的危险因素也与威胁视力的糖尿病视网膜病变相关。

关键数值与推荐

  • 任何糖尿病视网膜病变的年龄-性别标化患病率为27.9%(95%CI 27.2%~28.6%)。
  • 威胁视力的糖尿病视网膜病变的年龄-性别标化患病率为12.6%(95%CI 12.1%~13.1%)。
  • 威胁视力的糖尿病视网膜病变定义为存在增殖前期糖尿病视网膜病变(R2)、增殖期糖尿病视网膜病变(R3)和/或黄斑病变(M1)。
  • 多因素logistic回归中与糖尿病视网膜病变相关的因素:年龄(OR 0.967)、糖尿病病程(OR 1.093)、糖化血红蛋白(OR 1.115)、空腹血糖(OR 1.074)、收缩压(OR 1.014)、心率(OR 1.010)、低密度脂蛋白(OR 1.149)、甘油三酯(OR 0.975)、血尿素氮(OR 1.012)、血肌酐(OR 1.003)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the prevalence and risk factors for diabetic retinopathy (DR) and sight-threatening diabetic retinopathy (STDR) in a multi-hospital-based DR screening programme among patients with diabetes in China, the Lifeline Express Diabetic Retinopathy Screening Program. METHODS: Patients with diabetes in eight hospitals across mainland China (both southern and northern) from January 2014 to July 2016 were recruited in this programme. All participants underwent a standardised interview and examinations and received digital fundus photography. DR severity was graded from retinal fundus photographs by retina specialists in the reading centre of Joint Shantou International Eye Center, according to the grading standards of the English National Screening Programme. STDR was defined as the presence of preproliferative DR (R2), proliferative DR (R3) and/or maculopathy (M1). RESULTS: 16 305 patients with diabetes were screened for DR in total. Fundus photographs were gradable for 15 078 patients (92.5%). The age-gender-standardised prevalence of any DR and STDR was 27.9% (95% CI, 27.2% to 28.6%) and 12.6% (95% CI, 12.1% to 13.1%), respectively. In the multiple logistic regression analysis, younger age (OR, 0.967), longer duration of diabetes (OR, 1.093), higher haemoglobin A1c (OR, 1.115), higher fasting plasma glucose (OR, 1.074), higher systolic blood pressure (OR, 1.014), faster heart rate (OR, 1.010), higher low-density lipoprotein (OR, 1.149), lower triglycerides (OR, 0.975), higher blood urea nitrogen (BUN) (OR, 1.012) and elevated serum creatinine level (OR, 1.003) were associated with the presence of DR. Similar risk factors, except for BUN and triglycerides, were found for STDR. CONCLUSIONS: The prevalence of DR and STDR in diabetes was 27.9% and 12.6%, respectively in this multi-hospital-based population across China. Compared with Western population with diabetes, similar risk factors for DR and STDR were found in Chinese patients with diabetes.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Zhang G, Chen H, Chen W, et al. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017. PMID: 28855195. doi:10.1136/bjophthalmol-2017-310316

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。